Recs

19

5 Top Stocks at Half-Price

You love buying your shirts when they go on sale. And who can resist a buy-one-get-one-free offer? So when our stocks go on sale, why do we cry about their low prices?

Smart investors like Warren Buffett or Marty Whitman love it when their stocks are suddenly selling at bargain-basement prices. For them, these companies become no-brainer buys.

The investors who populate the Motley Fool CAPS community also like a bargain, apparently. Below, you'll find five stocks whose shares are selling at least 50% below their 52-week highs, but which still earn top honors from our investor-intelligence database. Consider it a BOGO sale on stocks.

Stock

CAPS Rating (out of 5)

% Off 52-Week High

Cemex (NYSE: CX  )

*****

72%

Mindray Medical (NYSE: MR  )

*****

58%

Precision Castparts (NYSE: PCP  )

*****

59%

Schlumberger (NYSE: SLB  )

*****

62%

XTO Energy (NYSE: XTO  )

*****

53%

Naturally, we want you to look a bit closer at these stocks before buying. You can get low-priced appliances in the dent-and-ding section of your home-remodeling superstore, but their quality might not be so good. Same thing here: Make sure there's nothing seriously wrong with the company before you plug it into your portfolio.

Take two, they're small
It's not easy to build much these days without the use of cement, so it would seem that Mexican cement maker Cemex would be positioned to do well as a result. Yet there's not much of anything being built these days, and with lower fuel costs making cheaper imported cement a more attractive option, Cemex may face increased profit pressures.

While a huge public-works program from the Obama administration could benefit companies like construction and engineering firms Fluor (NYSE: FLR  ) and Jacobs Engineering (NYSE: JEC  ) , some wonder whether it will come soon enough to be of benefit to Cemex. CAPS member Aggiemedic01 thinks the cement company will only gain advantage later on, and that next year remains a challenge for it:

High debt levels, much of which come due this year, coupled with a global slow down and extremely difficult financing environment will destroy this company. If the Obama administration is able to push an infrastructure-based stimulus package, the cement/concrete industry will benefit only after the engineering/design work is completed.

Heavy construction isn't the only industry placing bets on the new administration. Investors in XTO Energy are hoping that Obama's acceptance-speech pledge to tap the country's natural gas reserves will serve as a boon to the industry. CAPS All-Star anasr thinks the stock will initially walk in lockstep with oil, but that both will ultimately experience a strong upward surge:

XTO Energy will benefit from the current strong preference for natural gas as a partial substitute to oil. Natural gas is cleaner and cheaper than oil and the US is said to be 'floating' on that fuel. Besides, US President-elect has made it clear that he has a preference for natural gas. XTO is therefore one of a category of stocks that will benefit from the inevitable global veering toward natural gas. I expect XTO will move in lockstep with oil prices when these resume their ascending trend.

Have half a mind
It pays to start your own research on these stocks on Motley Fool CAPS. Read a company's financial reports, scrutinize key data and charts, and examine the comments your fellow investors have made, all from a stock's CAPS page.

Sign up today for the completely free service, and tell us whether these stocks are twice as good at half the price.

On Jan. 12, 2009, Fool co-founder David Gardner, Jeff Fischer, and their Motley Fool PRO team will accept new subscribers to their real-money portfolio service. Motley Fool PRO is investing $1 million of the Fool's own money in long and short positions in a range of securities, including common stocks, put and call options, and exchange-traded funds (ETFs). They also incorporate proprietary CAPS "community intelligence" data into their research. To learn more about Motley Fool PRO and to receive a private invitation to join, simply enter your email address in the box below.

Best Odds in the Universe!
If you're interested in a 98.79% chance at beating the market... and a 70.84% chance at DOUBLING the market's return – Motley Fool Supernova could be just what you're looking for. And get this: We arrived at these odds from 10,000 random back-tested portfolios composed of Motley Fool Co-founder David Gardner's personal stock picks.

It's why David recently handpicked a small team of world-class portfolio managers. You see, he thinks these odds can get even better! And he'd like to prove it to you...

Simply enter your email address. And the answer to the question everybody is asking will be delivered to your inbox!

Cemex is a Motley Fool Global Gains selection. Mindray Medical is a Rule Breakers pick. Precision Castparts and Cemex are Stock Advisor selections. The Fool owns shares of Mindray Medical and Cemex. Try any of our Foolish newsletters today, free for 30 days.

Fool contributor Rich Duprey does not have a financial position in any of the stocks mentioned in this article. You can see his holdings here. The Motley Fool has a disclosure policy.


Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On December 31, 2008, at 8:03 PM, mrchairman11 wrote:

    I think this was a great article; however, I do not agree with the CX choice.

    Cemex has a long way to go DOWN in my honest opinion, and it seems the author is making an assumption based on U.S. projection and this company has bought a lot of its competitors around the globe.

    I plan to purchase shares of this company once it gets to 5 and will buy on the way down. I missed the 4 dollar entry point in December; however, after earning are reported it's a play.

  • Report this Comment On January 01, 2009, at 9:17 AM, victorstocks wrote:

    Hi

    I m just wondering how it is that 2 reports (5 Deathbed Stocks? and 5 Top Stocks at Half Price) by the same author but the Caps ratings for CX are rate one star and 5 star. Did I missed anyhting?

    victor

  • Report this Comment On January 02, 2009, at 9:54 AM, palaceplace wrote:

    u.r. right. u can buy these 5 stox for 1/2 of today's price by the end of 09. u guys r nothing but paid TOUTS!!! U BELONG IN JAIL WITH bernie!!!!!!!!!!

  • Report this Comment On January 02, 2009, at 12:05 PM, bert111 wrote:

    Just because a stock has declined by 50 percent doesn't make it undervalued. DCF is problematic in this market and especially problematic if the prior growth/decline rate for free cash flows is unknown. With just four years worth of data for MR, there is insufficient data on which to value the company by DCF. Its price to net asset value is 5.37, which is not inexpensive or cheap. CX's price to book is high by any value investing metric, and it has an Altman Z score (bankruptcy risk) of 1.24 (well below the threshold of 1.81). All the others have price to adjusted book values well above 2.6 and a minority of prior years where Earnings-Power Value exceeded Replication Value -- the metric advocated by Columbia's Bruce Greenwald for identifying value stocks. In fact, only SLB and PCP have a single year where Earnings-Power exceeded Replication Value -- all others, by my calculations, failed to post one year where its moat or franchise value was realized in the numbers.

    I don't know about PalacePlace's assertion, but this group of recommendations strikes me as problematic when the fundamentals are considered, and they seem at odds with the Motley Fool's asserted focus on educating average investors to consider the fundamentals and the conventions of value investing.

    As for the star rating system, I consider it an invaluable service. While the vast majority of one- and two-star stocks are poor choices, those that have strong fundamentals tend to out-perform. When I first started posting on CAPS, the majority of my recommendations were two star stocks. The last time I checked, most had become four- or five-star stocks. The CAPS star system reflects the ebb and flow of investor sentiment and seems highly predictive in most cases, but when it fails it becomes profitable for the contrarian investor.

    In my view, the key is to Gretzky -- go where the puck will be, not where it is right now. That means looking for the void (strong company's with little investor interest at the moment). Riding the coat tails of others is only as strong as the coat tails (the company) or your grip on the coat tails (understanding of the fundamentals).

  • Report this Comment On January 02, 2009, at 3:24 PM, TMFGebinr wrote:

    Hi victorstocks,

    Thank you for catching that. Cemex is and has been a five-star stock and was mistakenly included in the Deathbed article, thanks to a glitch in a screening program. That error was serious enough (wasn't just Cemex) that we decided to remove the article entirely. Please note this is not our usual method of fixing mistakes. In fact, in the 1-1/4 years I've been here, that's the first one I've seen removed.

    Cheers,

    Jim Mueller

    Editor, The Motley Fool

Add your comment.

Compare Brokers

Fool Disclosure

DocumentId: 802618, ~/Articles/ArticleHandler.aspx, 2/14/2012 4:35:29 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 6 hours ago Sponsored by:
DOW 12,874.04 72.81 0.57%
S&P 500 1,351.77 9.13 0.68%
NASD 2,931.39 27.51 0.95%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

2/13/2012 4:00 PM
CX $8.56 Up +0.14 +1.66%
Cemex CAPS Rating: ****
PCP $170.93 Up +2.53 +1.50%
Precision Castpart… CAPS Rating: *****
SLB $78.03 Up +0.86 +1.11%
Schlumberger CAPS Rating: *****
XTO $41.81 Down +0.00 +0.00%
XTO Energy, Inc. CAPS Rating: *****
FLR $60.16 Up +0.59 +0.99%
Fluor Corporation CAPS Rating: *****
JEC $46.29 Up +0.44 +0.96%
Jacobs Engineering… CAPS Rating: ****
MR $29.66 Up +0.15 +0.51%
Mindray Medical In… CAPS Rating: ***

Advertisement